Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
GNAS
REST API REST API
Homo sapiens
GNAS is differentially expressed in 376 experiments: 202 organism parts: bone marrow, liver, ... (200 more);, 265 disease states: normal, control, ... (263 more);, 115 cell types 588 cell lines 59 compound treatments and 90 other conditions.
Synonyms GNASXL, GPSA, SCG6, NESP55, GNAS1, NESP
Orthologs GNAS (Gallus gallus)   Gnas (Mus musculus)   gnas (Danio rerio)   GNAS2_BOVIN (Bos taurus)   ENSCING00000005789 (Ciona intestinalis)   G-salpha60A (Drosophila melanogaster)   gnas (Xenopus laevis)   GNAS (Canis familiaris)   (Compare orthologs)
Gene Ontology Term plasma membrane, DNA methylation, GTPase activity, protein binding, behavior, cytoplasm, intracellular, intrinsic to membrane, ruffle, metal ion binding, G-protein coupled receptor protein signaling pathway, extracellular region, blood coagulation, membrane fraction, signal transducer activity, GTP catabolic process, guanyl-nucleotide exchange factor activity, multicellular organism growth, GTP binding, molecular_function, intracellular transport, cAMP biosynthetic process, activation of adenylate cyclase activity by dopamine receptor signaling pathway, activation of adenylate cyclase activity by G-protein signaling pathway, adenylate cyclase activity, protein secretion, sensory perception of smell, nucleotide binding, post-embryonic development, guanyl nucleotide binding, response to drug, cytoplasmic vesicle, sensory perception of chemical stimulus, tissue homeostasis, transmembrane transport, heterotrimeric G-protein complex, activation of adenylate cyclase activity, female pregnancy, mu-type opioid receptor binding, transport vesicle, energy reserve metabolic process, water transport, endochondral ossification, embryonic hindlimb morphogenesis, skin development, cartilage development, skeletal system development, genetic imprinting, extrinsic to internal side of plasma membrane, positive regulation of osteoblast differentiation, positive regulation of osteoclast differentiation, ionotropic glutamate receptor binding, embryonic cranial skeleton morphogenesis, trans-Golgi network membrane, regulation of insulin secretion, platelet activation, post-embryonic body morphogenesis, G-protein beta/gamma-subunit complex binding, cellular response to glucagon stimulus
InterPro Term Gprotein_alpha_su, Gprotein_alpha_S, NESP55, Small_GTPase_ARF/SAR
Gene-Disease Assocation PITUITARY ADENOMA, ACTH-SECRETING, PITUITARY ADENOMA, GROWTH HORMONE-SECRETING, PSEUDOHYPOPARATHYROIDISM, TYPE IB; PHP1B, GNAS COMPLEX LOCUS; GNAS, PSEUDOPSEUDOHYPOPARATHYROIDISM; PPHP, COLORECTAL CANCER; CRC, OSSEOUS HETEROPLASIA, PROGRESSIVE; POH, PSEUDOHYPOPARATHYROIDISM, TYPE IC; PHP1C, MCCUNE-ALBRIGHT SYNDROME; MAS, PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A, ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH
UniProt Accession P84996, P63092, B0AZR9, O95467, A6NI00, Q5JW64, Q5JWD1, Q5JWF2, Q5JWE8, Q5JWE9, A2A2S2, A2A2S1, A2A2R6
Search EB-eye ENSG00000087460
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-803, E-GEOD-15765, E-GEOD-6573, E-GEOD-1577, E-GEOD-7540, ... (36 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-5258, E-GEOD-4525, E-GEOD-19639, E-GEOD-18005, ... (47 experiments)

Factor Value U/D Experiments
MCF-7
4
E-GEOD-19639, E-GEOD-3529, E-GEOD-20081, E-GEOD-5823
SW480
3
E-GEOD-18005, E-MEXP-1014, E-MTAB-37
HL-60
1
3
E-GEOD-5258, E-GEOD-24147, E-MTAB-37, E-GEOD-96
BT-474
2
E-GEOD-3529, E-GEOD-5823
A549
2
E-GEOD-6013, E-GEOD-3202
GM15510
2
E-GEOD-19466, E-GEOD-22639
582 more value(s).


Cell type

studied in E-GEOD-21668, E-GEOD-3920, E-MEXP-750, E-GEOD-20677, E-TABM-34, ... (57 experiments)

Factor Value U/D Experiments
mononuclear cell
2
E-GEOD-6053, E-GEOD-7307
human foreskin fibroblast
2
E-GEOD-18265, E-GEOD-18147
embryonic stem cell
2
E-MEXP-930, E-GEOD-2248
fibroblast
2
E-GEOD-3920, E-GEOD-3204
human embryonic stem cell
2
E-GEOD-18265, E-GEOD-18147
testis - germ cell
2
E-AFMX-5, E-TABM-145
109 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-15960, E-GEOD-2466, E-GEOD-1577, E-MEXP-2280, ... (77 experiments)

Factor Value U/D Experiments
chronic myelogenous leukemia
3
E-GEOD-96, E-MTAB-37, E-GEOD-5550
colon carcinoma
3
E-MTAB-62, E-MTAB-37, E-GEOD-3726
lung adenocarcinoma
3
E-MTAB-37, E-MTAB-62, E-MEXP-231
neuroblastoma
3
E-GEOD-1825, E-MTAB-62, E-MTAB-37
prostate carcinoma
3
E-GEOD-96, E-MEXP-2034, E-MTAB-62
osteosarcoma
2
E-MTAB-62, E-MTAB-37
259 more value(s).


Compound treatment

studied in E-GEOD-1615, E-GEOD-5258, E-GEOD-3720, E-GEOD-5824, E-MEXP-1958, ... (33 experiments)

Factor Value U/D Experiments
ethanol
2
E-MEXP-2241, E-GEOD-3113
lipopolysaccharide
2
E-MEXP-1958, E-GEOD-3720
none
5
6
E-GEOD-5824, E-MEXP-1958, E-GEOD-4600, E-GEOD-412, E-MEXP-1601, ... (11 experiments)
HMB-PP (phosphoantigen)
1
E-MEXP-1601
filtered air
1
E-TABM-127
1mM GDC-0941
1
1
E-GEOD-20719
53 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
DMSO
1
1
E-GEOD-19519
thapsigargin
1
1
E-GEOD-19519
tunicamycin
1
1
E-GEOD-19519


Biosource provider
studied in E-MTAB-37

BioSourceProvider
studied in E-GEOD-19466, E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cancer site
studied in E-GEOD-4271

cd38
studied in E-GEOD-22601

Cell treatment
studied in E-MEXP-1192

Cellular component
studied in E-GEOD-1400

Chromosomal aberration
studied in E-TABM-125

Clinical history
studied in E-GEOD-22097, E-GEOD-19420, E-TABM-234, E-GEOD-19743, E-GEOD-7967, ... (11 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-17189, E-GEOD-6710, E-GEOD-19348, ... (11 experiments)

Clinical treatment
studied in E-GEOD-6532, E-GEOD-21610

coriell cell line repository identifier
studied in E-GEOD-19519

Date of sample preparation and hybridisation
studied in E-GEOD-22541

development stage
studied in E-GEOD-22601

Developmental stage
studied in E-GEOD-19743, E-GEOD-1614, E-GEOD-1638, E-GEOD-20033, E-GEOD-3140, ... (10 experiments)

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-89, E-GEOD-19743, E-GEOD-3325, E-GEOD-22148, E-MEXP-2280, ... (10 experiments)

Environmental stress
studied in E-GEOD-1643, E-GEOD-1518, E-GEOD-3720, E-GEOD-4086

Er
studied in E-GEOD-20194, E-GEOD-16716

Estrogen receptor status
studied in E-GEOD-6532, E-GEOD-20194, E-GEOD-16716

Ethnic group
studied in E-GEOD-20194, E-GEOD-16716

Ethnicity
studied in E-GEOD-16363

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-8023, E-MTAB-73, E-GEOD-7578, E-GEOD-17385, E-GEOD-20847, ... (8 experiments)

Genotype
studied in E-GEOD-1045, E-GEOD-17476, E-GEOD-2466, E-GEOD-22593, E-GEOD-18005, ... (15 experiments)

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-GEOD-5681, E-GEOD-7011, E-GEOD-20540, E-GEOD-22278, E-GEOD-10315, ... (14 experiments)

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Her2 status
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234, E-TABM-276, E-GEOD-20194, E-GEOD-16716

immunoprecipitated protein
studied in E-GEOD-21918

Individual
studied in E-TABM-325, E-MTAB-197, E-GEOD-974, E-GEOD-2466, E-MEXP-2069, ... (45 experiments)

Infection
studied in E-GEOD-2405, E-GEOD-12108, E-GEOD-12254, E-GEOD-980

Injury
studied in E-GEOD-19743

Karyotype
studied in E-GEOD-7214

Ki67 ihc
studied in E-GEOD-21653

Labeling
studied in E-LGCL-5

Light
studied in E-GEOD-1725

Lymph node status
studied in E-GEOD-6532

Material type
studied in E-MEXP-455, E-MEXP-958, E-MEXP-1082, E-GEOD-9171

Media
studied in E-MEXP-765

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

Nbefore
studied in E-GEOD-20194, E-GEOD-16716

Observation
studied in E-TABM-276

organ
studied in E-GEOD-24283

Organism
studied in E-GEOD-7540, E-GEOD-1801, E-TABM-84

Organism status
studied in E-GEOD-19188

Original diagnosis
studied in E-GEOD-21521

P53 ihc
studied in E-GEOD-21653

Performer
studied in E-GEOD-2004, E-LGCL-5

Phase
studied in E-GEOD-4888

Phenotype
studied in E-GEOD-19703, E-GEOD-22152, E-GEOD-21750, E-GEOD-6434, E-GEOD-1657, ... (7 experiments)

Population
studied in E-MTAB-197, E-GEOD-4922, E-GEOD-4342

Progesterone receptor status
studied in E-GEOD-6532

Protocol type
studied in E-GEOD-22097, E-GEOD-3254, E-GEOD-21837, E-GEOD-19445, E-GEOD-19246, ... (7 experiments)

Replicate
studied in E-GEOD-17204

Rna integrity
studied in E-TABM-325

RNAi
studied in E-MEXP-2115, E-GEOD-1703, E-GEOD-12438, E-MEXP-1509, E-GEOD-1676, ... (9 experiments)

Sample preparation
studied in E-GEOD-16728

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-16797, E-GEOD-19743, E-GEOD-21374, E-GEOD-17400, E-GEOD-18995 ... (5 experiments)

sbr grade
studied in E-GEOD-21653

Sex
studied in E-GEOD-1643, E-GEOD-2508, E-GEOD-2466, E-GEOD-7307

Sirna
studied in E-GEOD-21575

Stimulation
studied in E-GEOD-20114, E-GEOD-11886, E-GEOD-11428

stimulus
studied in E-GEOD-22103

Strain or line
studied in E-MEXP-1996, E-TABM-125

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-3494, E-GEOD-4922, E-GEOD-19188

Tbefore
studied in E-GEOD-20194, E-GEOD-16716

Test result
studied in E-GEOD-1926, E-TABM-276

tissue (organ)
studied in E-GEOD-22601

Translocation cyclin group
studied in E-GEOD-2912

Treatment
studied in E-GEOD-22369, E-GEOD-22368, E-GEOD-16837, E-GEOD-19246, E-GEOD-19815, ... (7 experiments)

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments 99 146
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-4290, E-GEOD-1561, E-GEOD-4922

Tumor size
studied in E-GEOD-8167

Vehicle
studied in E-GEOD-5258

weight of protein recovered
studied in E-GEOD-21918

Processing time: 0.485 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM